Precision medicine promises to improve patient care by matching each patient with the right treatment. Now, AI-assisted, digital biomarker assays may help make precision medicine available for more patients than ever. Paige’s Medical Director of Biomarker Development Dr. Joe Oakley explained how digital biomarker assays are trained, how they can be applied to the identification of relevant tumor features, and what this means for the future of cancer treatment in a new piece for MedCity News.
Read the full article on MedCity News
—
Oakley, J. (2023, May 10). AI Can Make Precision Medicine More Accessible to Patients Who Might Not Have Been Able to Benefit in the Past. MedCity News. https://medcitynews.com/2023/05/ai-can-make-precision-medicine-more-accessible-to-patients-who-might-not-have-been-able-to-benefit-in-the-past/
